The major shareholder roster of Mayne Pharma features a balanced mix of institutional investment management firms, specialized healthcare funds, and corporate insiders. Notable institutional stakeholders include domestic and international asset managers, specialized micro-cap equity funds, and activist investment entities—such as Cable Car Capital, which holds a significant percentage of the fully paid ordinary shares—alongside executive leadership and board members who maintain aligned economic interests in the long-term success of the enterprise.